Alkylating antineoplastic agent

Alkylating antineoplastic agents are a class of chemotherapy drugs that work by adding an alkyl group to the DNA of cancer cells. This process interferes with the cell's replication and transcription, ultimately leading to cell death. These agents are used in the treatment of various types of cancer, including leukemia, lymphoma, and solid tumors.

Mechanism of action

Alkylating agents exert their effects by forming covalent bonds with DNA. The alkyl group attaches to the guanine base of DNA, leading to cross-linking of DNA strands, abnormal base pairing, or strand breaks. This damage prevents the cancer cells from dividing and proliferating, triggering apoptosis or programmed cell death.

Types of alkylating agents

Alkylating agents can be classified into several categories based on their chemical structure and mechanism of action:

Nitrogen mustards

Nitrogen mustards are among the oldest alkylating agents and include drugs such as cyclophosphamide, ifosfamide, and chlorambucil. These agents are commonly used in the treatment of lymphomas and breast cancer.

Nitrosoureas

Nitrosoureas are unique in their ability to cross the blood-brain barrier, making them effective in treating brain tumors. Examples include carmustine and lomustine.

Alkyl sulfonates

Busulfan is a well-known alkyl sulfonate used primarily in the treatment of chronic myelogenous leukemia (CML).

Triazines

Dacarbazine and temozolomide are triazines used in the treatment of melanoma and glioblastoma, respectively.

Ethylenimines

Thiotepa is an ethylenimine used in the treatment of bladder cancer and as a conditioning agent before bone marrow transplantation.

Platinum-based drugs

Although not true alkylating agents, platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin are often grouped with them due to their similar mechanism of action. These drugs form cross-links with DNA, disrupting its function.

Side effects

The use of alkylating agents is associated with several side effects due to their impact on rapidly dividing cells. Common side effects include:

• Myelosuppression: A decrease in the production of blood cells, leading to anemia, leukopenia, and thrombocytopenia.
• Nausea and vomiting: Often managed with antiemetic medications.
• Alopecia: Hair loss, which is usually temporary.
• Infertility: Due to damage to reproductive cells.
• Secondary malignancies: There is an increased risk of developing secondary cancers, such as acute myeloid leukemia, years after treatment.

Clinical use

Alkylating agents are used in various chemotherapy regimens, often in combination with other drugs to enhance their efficacy. They are a cornerstone in the treatment of many cancers, including:

• Hodgkin's lymphoma
• Non-Hodgkin's lymphoma
• Multiple myeloma
• Ovarian cancer
• Testicular cancer

History

The development of alkylating agents began in the early 20th century with the discovery of the cytotoxic effects of mustard gas. This led to the synthesis of nitrogen mustards, which were the first chemotherapeutic agents used in the treatment of cancer. Over the years, numerous alkylating agents have been developed, expanding the arsenal of drugs available for cancer therapy.

Related pages

• Chemotherapy
• Cancer
• DNA repair
• Apoptosis

Triaziquone, an alkylating agent